More than thirty hires of scientific informants for Novabee, the company with commercial skills that has as its core business the distribution of Novavision Group products on the Italian territory. To which will be added, from now to the next few months, other dozens of contracts. Everything starts from a project that was carried out following a strategic agreement, entered into with the pharmaceutical company EuTylia. A partnership that translates in particular into the marketing of a device produced by Novaclinical, the business unit that deals with research and development of medical devices of Novavision.
This is Eva, a non-ablative solution for the most common pathologies of the female reproductive system. «The company’s commercial development plan – says Antonio Vitiello, CEO of Novabee – is proceeding exactly as planned. We strongly believe in the agreement signed with Eutylia and we are sure that the market will respond positively to this initiative, leading it to collect the same success already experienced by our devices “. The same enthusiasm also on the part of Vitale Esposito, CEO of EuTylia: «We are very proud of this partnership. The union between Novabee’s commercial network and ours, already established nationally in the pharmaceutical-gynecological sector, will lead us to achieve the set goals ».
Loading…
Novabee researches, studies and distributes latest generation devices for the aesthetic and medical sector. The company employs professionals from the pharmaceutical and parapharmaceutical world, from marketing, from e-commerce with experience in the management of commercial networks that have the common goal of sharing the knowledge developed in their respective areas of expertise to expand the market. through an enhancement of the range and services.